Bioadaptives Working Capital Growth & History (BDPT)

Bioadaptives's working capital was −$2.1M for fiscal 2025.

View full Bioadaptives company overview

Bioadaptives annual working capital history

Bioadaptives annual working capital

Fiscal yearPeriod endedWorking capitalChangeGrowth
20252025-12-31−$2.1M−$680,138
20242024-12-31−$1.5M$198,154
20232023-12-31−$1.7M−$207,581
20222022-12-31−$1.5M−$301,743
20212021-12-31−$1.2M$226,037
20202020-12-31−$1.4M−$538,909
20192019-12-31−$839,876−$233,946
20182018-12-31−$605,930
20152015-12-31−$203,901−$202,729
20142014-12-31−$1,172−$89,642
20132013-12-31$88,470

Bioadaptives working capital trends

Over the last five fiscal years, Bioadaptives's working capital decreased from −$1.4M to −$2.1M, a change of −$765,271. The latest reported quarter, Q2 2026, shows −$1.8M.

About the metric

What working capital means

Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.

Calculation and source

How working capital is calculated

TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Bioadaptives source filings ↗

Community posts

It’s quiet here.

No posts about BDPT yet. Start the conversation.

Write the first post